Immediate Impact
79 standout
Citing Papers
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
2025 Standout
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Works of Maria Yu being referenced
Adherence and persistence among patients with type 2 diabetes initiating dulaglutide compared with semaglutide and exenatide BCise : 6‐month follow‐up from US real‐world data
2020
Liraglutide Versus Exenatide Once Weekly: Persistence, Adherence, and Early Discontinuation
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Maria Yu | 612 | 290 | 56 | 136 | 32 | 702 | |
| Hitoshi Kuwata | 561 | 260 | 10 | 214 | 39 | 697 | |
| Jeffrey Unger | 711 | 363 | 10 | 194 | 14 | 817 | |
| Taner Damcı | 463 | 168 | 10 | 135 | 33 | 645 | |
| Jean‐François Yale | 413 | 161 | 31 | 195 | 28 | 752 | |
| Apostolos Manolopoulos | 384 | 212 | 6 | 132 | 21 | 580 | |
| K. Jameson | 450 | 93 | 17 | 142 | 14 | 596 | |
| Pierre Sérusclat | 701 | 367 | 5 | 197 | 25 | 827 | |
| Charles Atisso | 789 | 454 | 8 | 251 | 17 | 834 | |
| Cesare Berra | 482 | 237 | 6 | 183 | 37 | 757 | |
| Sri Prakash Mokshagundam | 284 | 132 | 14 | 126 | 28 | 583 |
All Works
Loading papers...